Meloni, M.; de Rooij, B.; Janssen, F.W.; Rescigno, F.; Lombardi, B.
Targeted Antibacterial Endolysin to Treat Infected Wounds on 3D Full-Thickness Skin Model: XZ.700 Efficacy. Pharmaceutics 2024, 16, 1539.
https://doi.org/10.3390/pharmaceutics16121539
AMA Style
Meloni M, de Rooij B, Janssen FW, Rescigno F, Lombardi B.
Targeted Antibacterial Endolysin to Treat Infected Wounds on 3D Full-Thickness Skin Model: XZ.700 Efficacy. Pharmaceutics. 2024; 16(12):1539.
https://doi.org/10.3390/pharmaceutics16121539
Chicago/Turabian Style
Meloni, Marisa, Bob de Rooij, Ferdinand W. Janssen, Francesca Rescigno, and Bernadette Lombardi.
2024. "Targeted Antibacterial Endolysin to Treat Infected Wounds on 3D Full-Thickness Skin Model: XZ.700 Efficacy" Pharmaceutics 16, no. 12: 1539.
https://doi.org/10.3390/pharmaceutics16121539
APA Style
Meloni, M., de Rooij, B., Janssen, F. W., Rescigno, F., & Lombardi, B.
(2024). Targeted Antibacterial Endolysin to Treat Infected Wounds on 3D Full-Thickness Skin Model: XZ.700 Efficacy. Pharmaceutics, 16(12), 1539.
https://doi.org/10.3390/pharmaceutics16121539